Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis. - Wikidata - wikimedia - TriplyDB

Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis.

Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis.

http://www.wikidata.org/entity/Q39911160

about

Applications of aptamers in targeted imaging: state of the art Role of periostin and its antagonist PNDA-3 in gastric cancer metastasis Inhibition of cell proliferation by an anti-EGFR aptamer Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers Development of an efficient targeted cell-SELEX procedure for DNA aptamer reagents.Highly stable aptamers selected from a 2'-fully modified fGmH RNA library for targeting biomaterials.DNA aptamers that target human glioblastoma multiforme cells overexpressing epidermal growth factor receptor variant III in vitro.Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigen.Generating aptamers by cell-SELEX for applications in molecular medicine Periostin-binding DNA aptamer inhibits breast cancer growth and metastasis.In Vivo Selection Against Human Colorectal Cancer Xenografts Identifies an Aptamer That Targets RNA Helicase Protein DHX9.Intracellular delivery of RNA-based therapeutics using aptamers.Aptamers: problems, solutions and prospects.Aptamers as targeted therapeutics: current potential and challenges.Cell-specific aptamers as emerging therapeutics.Status and Prospects of Aptamers as Drug Components.Development of a Single Stranded DNA Aptamer as a Molecular Probe for LNCap Cells Using Cell-SELEX.Next-generation sequencing as input for chemometrics in differential sensing routines.Advancement of the Emerging Field of RNA Nanotechnology.RNA aptamers and their therapeutic and diagnostic applications.Nucleic acids in human glioma treatment: innovative approaches and recent results Survey of the 2009 commercial optical biosensor literature.Current Advances in Aptamers for Cancer Diagnosis and Therapy.Toward the Selection of Cell Targeting Aptamers with Extended Biological Functionalities to Facilitate Endosomal Escape of Cargoes.Methods To Identify Aptamers against Cell Surface Biomarkers

P2860

Q27011511-1D14E7B8-CF15-46EF-9E70-F366578E7FDE Q28088349-CFBBBD77-1ED8-408E-83B1-2C3F135B35E9 Q28743866-38B21E31-D00C-486B-87E5-6EF212E71900 Q33832781-B324A1DB-6C1D-4A65-887D-26FE30511BC5 Q34964507-C00BB550-5922-4ABF-B3E7-CD609018A046 Q34979624-CB6E9184-F6BD-45E0-A51A-153A96CC351B Q35059032-2EFE37F2-6496-496B-87CE-47FA46062C3D Q35600421-B7D7800D-68EB-4EF1-A1D1-20E5165E985B Q35866033-9D70A053-5A55-4CD7-9F31-5D9F05D83F69 Q36883843-E66D9E55-647B-495A-B94E-211D5C35100B Q37238926-9752499B-F0D6-49F8-9B3E-EE08BC761460 Q37885186-FE7BE77D-FDF7-4B93-8D5D-ED6A5DA22F0F Q38181121-9A37530E-F5F7-427A-932E-FE865EDC2306 Q38290290-5F62F352-47FA-42FD-B245-FC7D7B62889F Q38302347-29A78E47-0CA1-464F-AFFB-E6727320C1BA Q38488502-4EA04A13-B2AA-467E-8681-DF5948D19F15 Q38827635-34915A15-422F-474F-A654-2C669B8BBCDB Q38892555-874A6D35-DBAF-4A44-A2F8-FB2CC50EF5B4 Q39065708-4A9B8169-E90E-47D0-A041-9ADFEF368272 Q39862703-0D283723-3CF0-421C-977B-8F1BE058A80E Q42111511-138A4048-91F3-431D-93B6-BCBDB7176C63 Q45399191-575AA2B1-60D5-4456-9E14-1CB6C71B1968 Q47561686-8FC634C0-B61F-440A-B23A-5F4D3029DAD2 Q53098100-7944CC63-FE2E-49A2-B63C-2E4D23AD0734 Q57018191-E2A2FC6F-F225-4CB9-8666-8E0C6AE7DADB

P2860

Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis.

http://www.wikidata.org/entity/Q39911160

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Aptamers selected against the ...... EGFRvIII and induce apoptosis.

@en

Aptamers selected against the ...... EGFRvIII and induce apoptosis.

@nl

type

label

Aptamers selected against the ...... EGFRvIII and induce apoptosis.

@en

Aptamers selected against the ...... EGFRvIII and induce apoptosis.

@nl

prefLabel

Aptamers selected against the ...... EGFRvIII and induce apoptosis.

@en

Aptamers selected against the ...... EGFRvIII and induce apoptosis.

@nl

P1433

Q39911160-E3A650A7-D541-4F25-874D-5C3040F86779

P1476

Q39911160-92140288-F8B9-4147-AE6E-A13A629E5AF5

P2093

Q39911160-1C0F1B95-3095-48FA-93CD-393E253CB638

Q39911160-2DEA02E2-95BD-4B7F-ADAF-97881ED22A41

Q39911160-49071557-FEB8-4992-AD02-533B770BBDFD

Q39911160-7845DB90-07D5-4138-8150-D56B8F8A96B2

Q39911160-E42C34C2-CACC-46BB-B842-A6B82DF0AC26

Q39911160-F5940235-6E1C-47CC-86D1-C9A2F5C9A528

P2860

Q39911160-1023B80A-839E-4DB8-B6F3-2CFCE0D0C214

Q39911160-1601DAEF-80DC-4389-B86F-E65D50E8DCA7

Q39911160-1E5F0085-FF6C-41F6-861A-90330A4DB428

Q39911160-1E75DED7-31B2-4818-B900-216F18EFDDDE

Q39911160-1FCF6CCC-1C7F-458E-93BC-F0F54498E6A8

Q39911160-2D9391FA-69C1-4FDA-A91F-E8DC16520A2E

Q39911160-3943424F-42F2-44C9-B500-186955EE3C4D

Q39911160-407117B5-E4D6-4F6D-ADF2-606F9FC7EB1A

Q39911160-46FE2D8E-BC38-49DF-B178-DEC3BD6A9C8D

Q39911160-515BD78A-9A75-44E6-B539-839A2ABB0300

P304

Q39911160-C3BC14F9-032D-47EE-9C70-F24A253F9008

P31

Q39911160-2CD73547-A1DF-403E-A37F-67684FBB5584

P356

Q39911160-4A7CBE0F-5EE1-47EE-943D-9B0CEDD720B6

P433

Q39911160-D09DD561-7CBA-4870-B791-93056FACC03B

P478

Q39911160-B79B08E1-B35E-4C13-9D96-3442D8712F31

P50

Q39911160-52ACBDAB-619C-479B-9F0F-D2A2F3CE569B

P577

Q39911160-5FEA9E96-CD43-4395-AF29-9F677FAB2279

P698

Q39911160-5C8D4E1F-2375-4011-871A-05F23AC6895A

P921

Q39911160-BB18347C-9D26-488E-958F-24536A84E04B

P932

Q39911160-77F7BDE3-24B7-42ED-A503-D9A606D7D1FF

P356

P1433

Biological Chemistry

P1476

Aptamers selected against the ...... EGFRvIII and induce apoptosis.

@en

P2093

Bruce A Sullenger

http://www.w3.org/2001/XMLSchema#string

Bryan M Clary

http://www.w3.org/2001/XMLSchema#string

Chien-Tsun Kuan

http://www.w3.org/2001/XMLSchema#string

Jing Mi

http://www.w3.org/2001/XMLSchema#string

Xiuwu Zhang

http://www.w3.org/2001/XMLSchema#string

Yingmiao Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains

The protein tyrosine kinase family of the human genome

Emerging clinical applications of RNA

RNA aptamers as reversible antagonists of coagulation factor IXa.

Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring.

EGF mutant receptor vIII as a molecular target in cancer therapy.

Epidermal growth factor receptor: mechanisms of activation and signalling.

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.

Why the epidermal growth factor receptor? The rationale for cancer therapy.

Targeting the epidermal growth factor receptor for cancer therapy.

P304

137-144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/BC.2009.022

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

390

http://www.w3.org/2001/XMLSchema#string

P50

Darell D. Bigner

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19040357

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

3816755

http://www.w3.org/2001/XMLSchema#string